| P50 | author | Ovokeraye Achinike-Oduaran | Q58171679 |
| | Greg Elmer | Q67249076 |
| P2093 | author name string | Carrie House | |
| | Norman H Lee | |
| | Cheryl L Mayo | |
| | Jenica D Tapocik | |
| | Bryan Frank | |
| | Troung Luu | |
| | Russell Williams | |
| | Noah Letwin | |
| P2860 | cites work | DeltaFosB: a sustained molecular switch for addiction | Q24555194 |
| | Identifying biological themes within lists of genes with EASE | Q24630875 |
| | Cluster analysis and display of genome-wide expression patterns | Q24644463 |
| | Within the fold: assessing differential expression measures and reproducibility in microarray assays. | Q24793654 |
| | Analysis of strain and regional variation in gene expression in mouse brain | Q24805884 |
| | Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats | Q24806600 |
| | Role for a bidentate ribonuclease in the initiation step of RNA interference | Q27860832 |
| | Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray | Q28202142 |
| | Possible physiological role of H19 RNA | Q28204018 |
| | A MicroRNA feedback circuit in midbrain dopamine neurons | Q28513149 |
| | Involvement of protein kinase Cgamma isoform in morphine-induced reinforcing effects | Q28588196 |
| | A brain-specific microRNA regulates dendritic spine development | Q29614753 |
| | Identifying differentially expressed genes using false discovery rate controlling procedures | Q29615200 |
| | Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray | Q30892639 |
| | Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla of rats | Q31883785 |
| | Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes | Q33246682 |
| | A genomic screen for activators of the antioxidant response element | Q33278661 |
| | Transcriptional profiling of C57 and DBA strains of mice in the absence and presence of morphine. | Q33279171 |
| | Gene expression profile of neuronal progenitor cells derived from hESCs: activation of chromosome 11p15.5 and comparison to human dopaminergic neurons. | Q33313877 |
| | The neurobiology of opiate reinforcement | Q33647133 |
| | Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. | Q33692830 |
| | Genetic analysis of inherited hypertension in the rat. | Q33807196 |
| | Molecular mechanisms and regulation of opioid receptor signaling | Q33932163 |
| | Cellular and synaptic adaptations mediating opioid dependence. | Q34127771 |
| | Neurobiology of addiction | Q34390258 |
| | Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. | Q34462175 |
| | DNA arrays and neurobiology--what's new and what's next? | Q34942397 |
| | The imprinted H19 noncoding RNA is a primary microRNA precursor | Q35641214 |
| | Interpretation of knockout experiments: the congenic footprint. | Q35839829 |
| | Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence | Q35908741 |
| | Chromosome Mapping of Gene Loci Affecting Morphine and Amphetamine Responses in BXD Recombinant Inbred Mice | Q36330305 |
| | Morphine effects on striatal transcriptome in mice | Q36672435 |
| | Microarrays: an overview | Q36749123 |
| | Neuroplasticity mediated by altered gene expression | Q36922912 |
| | Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. | Q38334846 |
| | Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice | Q39458411 |
| | Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters | Q40142289 |
| | Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice | Q40286769 |
| | Conditioned place preference and locomotor sensitization after repeated administration of cocaine or methamphetamine in rats treated with epidermal growth factor during the neonatal period. | Q40468315 |
| | The role of the basal ganglia in nociception and pain | Q40506202 |
| | Opioid control of MAP kinase cascade | Q40508531 |
| | Identification of Src transformation fingerprint in human colon cancer | Q40698849 |
| | Transcription of the mouse mu-opioid receptor gene is regulated by two promoters | Q41078375 |
| | Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/ and DBA/2 strains | Q41680280 |
| | Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants | Q42526118 |
| | Molecular networks in Dahl salt-sensitive hypertension based on transcriptome analysis of a panel of consomic rats | Q42652986 |
| | Quantitative trait loci influencing morphine antinociception in four mapping populations. | Q43649309 |
| | CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. | Q43651581 |
| | Functional interaction between opioid and cannabinoid receptors in drug self-administration. | Q43662870 |
| | Regional mu opioid receptor regulation of sensory and affective dimensions of pain | Q43673019 |
| | Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. | Q43907014 |
| | Chronic morphine treatment alters endogenous opioid control of hippocampal mossy fiber synaptic transmission | Q43971279 |
| | Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains | Q44126663 |
| | Affective analgesia following the administration of morphine into the amygdala of rats | Q44257137 |
| | Transgenic superoxide dismutase mice differ in opioid-induced analgesia. | Q44332710 |
| | Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon. | Q44333140 |
| | Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance | Q44334528 |
| | Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity | Q44337241 |
| | Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats | Q44344755 |
| | The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice | Q44347276 |
| | A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization | Q44348585 |
| | Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence | Q44352053 |
| | PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice | Q44924194 |
| | Mapping of a quantitative trait locus for morphine withdrawal severity | Q45085247 |
| | Confirmation of a major QTL influencing oral morphine intake in C57 and DBA mice using reciprocal congenic strains | Q45126959 |
| | An essential role for DeltaFosB in the nucleus accumbens in morphine action | Q46896171 |
| | Physiogenomic resources for rat models of heart, lung and blood disorders | Q48103779 |
| | Associating quantitative behavioral traits with gene expression in the brain: searching for diamonds in the hay. | Q48385345 |
| | Prefrontal influences upon the midbrain: a possible route for pain modulation | Q48469071 |
| | Combined application of behavior genetics and microarray analysis to identify regional expression themes and gene-behavior associations. | Q48535271 |
| | Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors. | Q48566183 |
| | Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice | Q48655768 |
| | Cross-talk of expression quantitative trait loci within 2 interacting blood pressure quantitative trait loci. | Q51577653 |
| | The antinociceptive effect of morphine is reversed by okadaic acid in morphine-naive but not in morphine-tolerant mice. | Q51770072 |
| | Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration. | Q51771735 |
| | Associative and nonassociative tolerance: the effects of dose and interdose interval. | Q52194854 |
| | Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. | Q52272626 |
| | Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. | Q53928500 |
| | Genotype-dependent sensitivity and tolerance to morphine and heroin: dissociation between opiate-induced running and analgesia in the mouse | Q68816521 |
| | Evidence for the dissociation of morphine analgesia, tolerance and dependence | Q69868594 |
| | A study of oral morphine preference in inbred mouse strains | Q72117570 |
| | Genetic variability in morphine sensitivity and tolerance between different strains of rats | Q73822284 |
| | Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests | Q74435399 |
| | De-differentiation-derived mesenchymal stem cells demonstrate selective repression in H19 bioregulatory RNA gene expression | Q81154406 |
| | Transcriptional profiling with a blood pressure QTL interval-specific oligonucleotide array | Q81309079 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5295-5307 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine | |
| P478 | volume | 29 | |